Comparative cardiovascular safety of nonsteroidal anti‐inflammatory drugs in patients with hypertension: a population‐based cohort study

No abstract is available for this paper.

• Publication year

  2018

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bcp.13537PMID 29468706PMCID PMC5903261
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative cardiovascular safety of nonsteroidal anti‐inflammatory drugs in patients with hypertension: a population‐based cohort study

  2018cited by this paper
• Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data

  2017cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

  2017cited by this paper
• Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.

  2017cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes

  2017cited by this paper
• Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.

  2016cited by this paper
• Validation of methods for assessing cardiovascular disease using electronic health data in a cohort of Veterans with diabetes

  2016cited by this paper
• Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study

  2016cited by this paper
• Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Chronic Kidney Disease in Subjects With Hypertension: Nationwide Longitudinal Cohort Study

  2015cited by this paper
• Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database.

  2015cited by this paper
• Association of Short-Term Use of Nonsteroidal Anti-Inflammatory Drugs With Stroke in Patients With Hypertension

  2015cited by this paper
• Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France.

  2014cited by this paper
• Application of marginal structural models in pharmacoepidemiologic studies: a systematic review

  2014cited by this paper
• Variability in the response to non-steroidal anti-inflammatory drugs: mechanisms and perspectives.

  2014cited by this paper
• Administrative Hospitalization Database Validation of Cardiac Procedure Codes

  2013cited by this paper
• Relative Cardiovascular and Gastrointestinal Safety of Non-selective Non-steroidal Anti-inflammatory Drugs Versus Cyclo-oxygenase-2 Inhibitors

  2013cited by this paper
• Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

  2013cited by this paper
• Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies

  2013cited by this paper
• Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples.

  2011cited by this paper
• Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies

  2011cited by this paper
• Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

  2011cited by this paper
• Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals

  2010cited by this paper
• Increased Risk of Stroke Associated With Nonsteroidal Anti-Inflammatory Drugs: A Nationwide Case–Crossover Study

  2010cited by this paper
• Cardiovascular Risks of Nonsteroidal Antiinflammatory Drugs in Patients After Hospitalization for Serious Coronary Heart Disease

  2009cited by this paper
• Observational Studies Analyzed Like Randomized Experiments: An Application to Postmenopausal Hormone Therapy and Coronary Heart Disease

  2008cited by this paper
• Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?

  2008cited by this paper
• General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

  2008cited by this paper
• Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups.

  2008cited by this paper
• Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population.

  2008cited by this paper
• Risk management profile of etoricoxib: an example of personalized medicine

  2008cited by this paper
• Association between nonnaproxen NSAIDs, COX‐2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study

  2007cited by this paper
• Thromboembolic Cardiovascular Risk Among Arthritis Patients Using Cyclooxygenase-2-Selective Inhibitor or Nonselective Cyclooxygenase Inhibitor Nonsteroidal Anti-inflammatory Drugs

  2007cited by this paper
• Risk of myocardial infarction associated with selective COX‐2 inhibitors: Meta‐analysis of randomised controlled trials

  2007cited by this paper
• Cyclooxygenase‐2 selectivity of non‐steroidal anti‐inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident

  2007cited by this paper
• Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

  2006cited by this paper
• Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.

  2006cited by this paper
• Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.

  2006cited by this paper
• Accuracy of ICD-9-CM Codes for Identifying Cardiovascular and Stroke Risk Factors

  2005cited by this paper
• The sad story of Vioxx, and what we should learn from it.

  2004cited by this paper
• Adjusted survival curves with inverse probability weights

  2004cited by this paper
• Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic

  2004cited by this paper
• Drug switching patterns among patients taking non‐steroidal anti‐inflammatory drugs: a retrospective cohort study of a general practitioners database in the United Kingdom

  2001cited by this paper
• Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

  2000cited by this paper
• Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

  2000cited by this paper
• A study of the longitudinal utilization and switching-patterns of non-steroidal anti-inflammatory drugs using a pharmacy based approach.

  1997cited by this paper
• Inaccuracy of the International Classification of Diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease

  1997cited by this paper
• The International Journal of Biostatistics Causal Inference from Longitudinal Studies with Baseline Randomization

  year unknowncited by this paper

• Drug Interactions in Geriatric Patients: An Evidence-Based Review of the Combination of Antihypertensives and Non-Steroidal Anti-Inflammatory Drugs

  2026cites this paper
• Management of patients in the elderly with osteoarthritis (Methodological recommendations of the Russian Association of Gerontologists and Geriatricians)

  2025cites this paper
• Pharmacovigilance analysis of small bowel bleeding associated with NSAIDs

  2025cites this paper
• Biochemical and histopathological evaluation of the potential ameliorating effects of Spirulina platensis against acute hepatorenal toxicity of diclofenac sodium in male rats

  2024cites this paper
• Exploration of Inflammatory Biomarkers and Psychological Cardiovascular Disease Risk Factors Among Community Dwelling Adults: A Gender Comparison Study

  2023cites this paper
• Comparison of toxic effects of some nonsteroidal anti-inflammatory medications on the kidney and lung tissues of rats

  2022cites this paper
• Efficacy and safety of Yaobitong capsule for acute lumbar disc herniation: A protocol for a multi-center randomized controlled trial

  2022cites this paper
• Chronic pain in older and senile patients. Clinical guidelines

  2021cites this paper
• New‐user and prevalent‐user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices

  2021cites this paper
• Medication as a risk factor for hospitalization due to heart failure and shock: a series of case-crossover studies in Swiss claims data

  2020cites this paper
• U.S. trends in prescription nonsteroidal anti‐inflammatory drug use among patients with cardiovascular disease, 1988–2016

  2020cites this paper
• Нежелательные реакции со стороны сердечно-сосудистой системы при приеме нестероидных противовоспалительных препаратов, и пути их снижения Adverse Reactions of the Cardiovascular System when Taking Nonsteroidal Anti-inflammatory Drugs and Ways to Reduce Them АКТУАЛЬНЫЕ ВОПРОСЫ КЛИНИЧЕСКОЙ ФАРМАКОЛОГИ

  2019cites this paper
• Adverse Reactions of the Cardiovascular System when Taking Nonsteroidal Anti-inflammatory Drugs and Ways to Reduce Them

  2019cites this paper
• Ibuprofen Safety at the Golden Anniversary: Are all NSAIDs the Same? A Narrative Review

  2019cites this paper
• Indomethacin impairs mitochondrial dynamics by activating the PKCζ–p38–DRP1 pathway and inducing apoptosis in gastric cancer and normal mucosal cells

  2019cites this paper
• Comparative cardiovascular safety of nonsteroidal anti‐inflammatory drugs in patients with hypertension: a population‐based cohort study

  2018cites this paper